Published in Gut on June 01, 1989
Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol (1992) 3.97
Detection of Helicobacter pylori by using the polymerase chain reaction. J Clin Microbiol (1991) 2.84
Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori. Gut (1991) 2.64
The urea breath test for Helicobacter pylori. Gut (1994) 2.07
Simplified single sample 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology. Gut (1991) 2.04
Long term serological surveillance after treatment of Helicobacter pylori infection. Gut (1991) 1.90
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ (1994) 1.78
Real-time quantitative PCR for detection of Helicobacter pylori. J Clin Microbiol (2002) 1.39
High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut (1995) 1.29
Breath ammonia measurement in Helicobacter pylori infection. Dig Dis Sci (2002) 0.99
15NH4+ excretion test: a new method for detection of Helicobacter pylori infection. J Clin Microbiol (1992) 0.95
Quantitative study of Helicobacter pylori in gastric mucus by competitive PCR using synthetic DNA fragments. J Clin Microbiol (1996) 0.94
14C-urea breath test for C pylori. Gut (1989) 0.94
Imprint cytology--a cheap, rapid and effective method for diagnosing Helicobacter pylori. Postgrad Med J (1993) 0.89
Comparison of the 13C-urea breath test and the endoscopic phenol red mucosal pH test in the quantification of Helicobacter pylori infection loading. Korean J Intern Med (2008) 0.81
Density of gastric Helicobacter pylori colonization is not associated with occurrence of dyspeptic symptoms. Dig Dis Sci (1997) 0.81
Effect of a test meal on the intragastric distribution of urea in the 13C-urea breath test for Helicobacter pylori. Gut (1995) 0.79
PCR detection of colonization by Helicobacter pylori in conventional, euthymic mice based on the 16S ribosomal gene sequence. Clin Diagn Lab Immunol (1996) 0.78
Short-term follow-up by serology of patients given antibiotic treatment for Helicobacter pylori infection. J Clin Microbiol (1998) 0.77
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90
Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust (1985) 8.49
Spiral organisms in endoscopic biopsies of the human stomach. J Clin Pathol (1984) 8.46
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Relation of Campylobacter pyloridis to gastritis and peptic ulcer. J Infect Dis (1986) 5.09
Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02
Spiral bacteria of the gastric antrum. Lancet (1984) 4.74
Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut (1986) 4.47
Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa. J Infect Dis (1987) 3.69
Breath test for altered bile-acid metabolism. Lancet (1971) 3.60
Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut (1985) 3.48
Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis. J Nucl Med (1988) 2.80
14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68
Pyloric campylobacter serology. Lancet (1984) 2.43
Campylobacter pylori in abattoir workers: is it a zoonosis? Lancet (1988) 2.41
Prenatal diagnosis of congenital rubella. Lancet (1984) 2.31
Distribution of the Ca (Oxford) antigen in lung neoplasms and non-neoplastic lung tissues. J Clin Pathol (1984) 1.35
Antibody titres to Campylobacter pylori after treatment for gastritis. BMJ (1988) 1.27
Breath analysis: gastroenterological applications. Gastroenterology (1974) 1.03
Breath-analysis tests in gastroenterology. Gut (1974) 1.01
Alteration of CO2 production during nonfasting isotopic CO2 breath tests: concise communication. J Nucl Med (1981) 0.88
Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet (1990) 9.49
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol (1986) 5.15
The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69
Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet (1993) 4.55
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology (1989) 4.23
Functional gastroduodenal disorders. Gut (1999) 3.74
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet (1997) 3.12
Needle-knife sphincterotomy as a precut procedure: a retrospective evaluation of efficacy and complications. Endoscopy (1996) 3.12
Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology (2001) 2.85
Recurrent massive haematemesis from Dieulafoy vascular malformations--a review of 101 cases. Gut (1986) 2.74
Regular review: treatment of Helicobacter pylori infection. BMJ (2000) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis (1996) 2.66
Genotypical variation of Campylobacter pylori from gastric mucosa. J Clin Microbiol (1990) 2.55
Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc (1996) 2.54
Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38
The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology (1999) 2.37
Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter (1996) 2.26
Collagenous sprue--an unrecognized type of malabsorption. N Engl J Med (1970) 2.21
Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol (1997) 2.18
Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology (1996) 2.17
A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther (1999) 2.14
Treatment of bile duct lesions after laparoscopic cholecystectomy. Gut (1996) 2.12
Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China. J Infect Dis (1998) 2.09
Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology (1978) 2.07
[Changed diagnosis and treatment of hepatocellular carcinoma]. Ned Tijdschr Geneeskd (1996) 2.04
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut (1992) 1.96
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut (1999) 1.94
Time trends in gastric carcinoma: changing patterns of type and location. Am J Gastroenterol (1992) 1.88
cagA-positive Helicobacter pylori populations in China and The Netherlands are distinct. Infect Immun (1998) 1.84
Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. Am J Clin Pathol (1996) 1.84
Endoscopic palliative treatment in pancreatic cancer. Gastrointest Endosc (1986) 1.84
Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations. Gut (1976) 1.83
Biliary endoprostheses in elderly patients with endoscopically irretrievable common bile duct stones: report on 117 patients. Gastrointest Endosc (1995) 1.82
Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenterol (1996) 1.80
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology (1997) 1.79
Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther (1999) 1.76
Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology (1988) 1.75
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group. Eur J Gastroenterol Hepatol (1995) 1.74
Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology (1999) 1.74
Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system. Gastroenterology (1989) 1.70
Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension. Eur J Gastroenterol Hepatol (1996) 1.70
Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol (1997) 1.69
Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology (1990) 1.67
Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology (1997) 1.67
Impaired anamnestic cellular immune response in patients with Crohn's disease. Gut (1975) 1.65
A patient with osteomalacia as single presenting symptom of gluten-sensitive enteropathy. J Intern Med (1992) 1.64
Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. Gastroenterology (1995) 1.61
Benign biliary strictures. Surgery or endoscopy? Ann Surg (1993) 1.59
Intestinal endotoxemia. Clinical significance. Gastroenterology (1988) 1.59
Loss of E-cadherin expression in early gastric cancer. Histopathology (1999) 1.59
Intragastric balloons for morbid obesity: results, patient tolerance and balloon life span. Br J Surg (1990) 1.58
Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol (1999) 1.57
The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol (1998) 1.56
Detection of Campylobacter pylori in stomach tissue by DNA in situ hybridisation. J Clin Pathol (1989) 1.53
Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia. J Infect Dis (1988) 1.52
Bile duct injury after laparoscopic cholecystectomy: the value of endoscopic retrograde cholangiopancreatography. Gut (1993) 1.52
Clogging of biliary endoprostheses: a new perspective. Gut (1990) 1.52
Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51
Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function. Gastroenterology (2001) 1.51
Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy (1999) 1.51
Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis. Gut (1982) 1.51
Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut (1998) 1.50
A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule. Am J Gastroenterol (2000) 1.50
A randomized trial of endoscopic balloon dilation and endoscopic sphincterotomy for removal of bile duct stones in patients with a prior Billroth II gastrectomy. Gastrointest Endosc (2001) 1.49
Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut (1999) 1.49
Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc (2001) 1.48
Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann Intern Med (1996) 1.48
Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa. J Clin Pathol (1994) 1.44
Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy. A follow-up analysis. Gastroenterology (1977) 1.44
Analysis of a positional candidate gene for inflammatory bowel disease: NRAMP2. Inflamm Bowel Dis (2000) 1.44
A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Endoscopy (1998) 1.44
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scand J Gastroenterol (1995) 1.43
Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis (1994) 1.42
Results of conservative treatment of benign esophageal strictures: a follow-up study in 100 patients. Gastroenterology (1982) 1.42
Treatment of instrumental oesophageal perforation. Gut (1984) 1.40
Suppression of Helicobacter pylori infection during intensive care stay: related to stress ulcer bleeding incidence? J Crit Care (2001) 1.40
Gastric metaplasia and Helicobacter pylori infection. Gut (1993) 1.40
Geographical variance in the risk of gastric stump cancer: no increased risk in Japan? Jpn J Cancer Res (1991) 1.39
[Barrett's esophagus: endoscopic treatment of high-grade dysplasia and early cancer]. Ned Tijdschr Geneeskd (2003) 1.39
[Barrett esophagus and Barrett carcinoma]. Ned Tijdschr Geneeskd (1997) 1.39
Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain. Aliment Pharmacol Ther (2006) 1.39
Positioning of a plastic prosthesis under fiberendoscopic control in the palliative treatment of cardio-esophageal cancer. Endoscopy (1976) 1.37
Precut papillotomy via fine-needle knife papillotome: a safe and effective technique. Gastrointest Endosc (1986) 1.36
Endoscopic placement of expandable metal stents for biliary strictures--a preliminary report on experience with 33 patients. Endoscopy (1989) 1.35
Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. J Infect Dis (1990) 1.35
The efficacy of endoscopic treatment of pancreatic pseudocysts. Gastrointest Endosc (1995) 1.34
Long-term follow-up after biliary stent placement for postoperative bile duct stenosis. Gastrointest Endosc (2001) 1.34
Acute phlegmonous gastritis. Gastrointest Endosc (1996) 1.34
Endoscopic ultrasonography for the evaluation of smooth muscle tumors in the upper gastrointestinal tract: an experience with 42 cases. Gastrointest Endosc (1990) 1.34
Evaluation of the performance of commercial test kits for detection of Helicobacter pylori antibodies in serum. J Clin Microbiol (1992) 1.33
Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology (1997) 1.31